Frequency Therapeutics Inc

NASDAQ:FREQ   4:00:00 PM EDT
2.00
-0.24 (-10.71%)
7:09:13 PM EDT: $2.10 +0.10 (+5.00%)
Other Pre-Announcement

Frequency Therapeutics Inc Reports Q3 Loss Per Share Of $0.55

Published: 11/08/2022 21:35 GMT
Frequency Therapeutics Inc (FREQ) - Frequency Therapeutics Provides Business Updates and Third Quarter 2022 Financial Results.
Frequency Therapeutics - Enrollment Completed for Phase 2b Study of Fx-322 for Treatment of Sensorineural Hearing Loss; Readout Expected in Q1 2023.
Qtrly Loss per Share $0.55.
Q3 Earnings per Share View $-0.57 -- Refinitiv Ibes Data (analyst estimates).